We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 597

Seventh Circuit leaves Sen. Ron Johnson without a leg to stand on in his Obamacare suit

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • April 16 2015

On Tuesday, April 14, 2015 the Seventh Circuit affirmed dismissal of a lawsuit by U.S. Senator Ron Johnson of Wisconsin in Johnson v. U.S. Office of

Apotex has standing despite Benicar patent disclaimer

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • April 9 2015

In Apotex Inc. v. Daiichi Sankyo, Inc., the Federal Circuit held that Apotex has standing to seek a declaratory judgment that it does not infringe

Waiting on Sequenom

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • April 7 2015

As I write this there’s a voice in my head saying, “Be careful what you wish for!” but it has been five months since Sequenom was argued at the

Supreme Court holds providers cannot sue states to challenge low Medicaid rates

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • April 3 2015

The Supreme Court ruled, on March 31, in a 5-4 decision, that hospitals and all other providers cannot sue to force a State to pay higher Medicaid

CMS releases Stage 3 meaningful use proposed rule

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • April 2 2015

The Centers for Medicare & Medicaid Services (“CMS”) released the Stage 3 proposed rule to the Medicare and Medicaid Electronic Health Records

Senate vows to address Medicare physician reimbursement cut in mid-April

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • April 1 2015

The Senate adjourned around 3:30 a.m. Friday, March 27, 2015 without passing legislation to hold off a scheduled 21 percent cut in Medicare physician

No collateral challenge of patent application revival

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • March 31 2015

In Exela Pharma Sciences, LLC v. Lee, the Federal Circuit held that the USPTO's decision to revive a patent application &8220;is not subject to

Repositioning of nursing homes to alternative models of care

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • March 31 2015

The juncture of the increasing drive to lower healthcare costs, consumer preferences for at home care or care in more residential environments, and

Avoiding liability for opinions in registration statements

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • March 31 2015

The recent U.S. Supreme Court decision in Omnicare, Inc. v. Laborers District Council Construction Industry Pension Fund, No. 13-435 (U.S. Mar. 24

Perspectives on the President’s precision medicine initiative

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • March 30 2015

President Obama’s “precision medicine initiative” earmarked over $200 million from his proposed 2016 budget to “bring us closer to curing diseases